共 50 条
- [3] THE IMPORTANCE OF CYTOMEGALO-VIRUS IN HEART-LUNG TRANSPLANT RECIPIENTS [J]. CHEST, 1989, 95 (03) : 627 - 631
- [5] MORBIDITY OF CYTOMEGALO-VIRUS INFECTION IN RECIPIENTS OF HEART OR HEART-LUNG TRANSPLANTS WHO RECEIVED CYCLOSPORINE [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06): : 1182 - 1191
- [6] GANCICLOVIR FOR SEVERE CYTOMEGALO-VIRUS INFECTION IN TRANSPLANT RECIPIENTS [J]. LANCET, 1988, 2 (8620): : 1137 - 1138
- [7] GANCICLOVIR FOR SEVERE CYTOMEGALO-VIRUS INFECTION IN TRANSPLANT RECIPIENTS [J]. LANCET, 1988, 2 (8626-7): : 1501 - 1502
- [8] GANCICLOVIR FOR CYTOMEGALO-VIRUS INFECTION IN RENAL-TRANSPLANT RECIPIENTS [J]. LANCET, 1989, 1 (8631): : 216 - 217
- [9] IMPORTANCE OF CYTOMEGALO-VIRUS IN HEART-LUNG TRANSPLANTATION [J]. THORAX, 1988, 43 (10) : P807 - P808
- [10] Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1996, 15 (09): : 881 - 887